NCT03533881 is a NA clinical trial of Arom Digest Slim in Metabolic Syndrome, sponsored by SC Aromaarmony SRL.

Who is sponsoring NCT03533881?

NCT03533881 is sponsored by SC Aromaarmony SRL.

What drugs are being tested in NCT03533881?

Interventions in NCT03533881: Arom Digest Slim, Nutritional changes.

What condition does NCT03533881 study?

NCT03533881 studies Metabolic Syndrome.

Is NCT03533881 still recruiting?

NCT03533881 is currently status unknown. Last updated 23 May 2018.

Last reviewed 2018-05-23 · How we verify

NCT03533881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Arom Digest Slim on Metabolic Profile and Food Behaviour in Overweight Persons

Status unknown NA Last updated 23 May 2018

What this trial tests

NA trial testing Arom Digest Slim in Metabolic Syndrome in 50 participants. Status unknown.

Timeline

16 April 2018

Primary endpoint
15 February 2019

15 April 2019

Quick facts

Lead sponsor	SC Aromaarmony SRL
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	50
Start date	16 April 2018
Primary completion	15 February 2019
Estimated completion	15 April 2019
Sites	1 location across Romania

Drugs / interventions tested

Arom Digest Slim
Nutritional changes

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →

Sponsor

SC Aromaarmony SRL

Who can join

Adults 18 to 60, female only, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to evaluate the efficacy of Arom Digest Slim in facilitating weight reduction along with a series of minimal nutritional interventions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03533881 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SC Aromaarmony SRL
Last refreshed: 23 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing